Balanced news tone
News Sentiment
MERK sentiment intelligence
PT Merck Tbk news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
56
Balanced news tone
24 relevant articles
News tone and price action are not far from neutral.
90/100 classification confidence.
directly relevant articles
high-authority source matches
-2.4% over one week, -9.6% over four weeks, trend active, and near fair-value range.
Merck Stock In Focus As Combination Therapies Shape Healthcare
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Primary event
Market update
90/100 classification
One-week reaction
-2.4%
Price reacting lower
Trend fit
Trend active
-9.6% over four weeks
Fair value
0.7%
Near fair-value range
Sentiment Mix
Positive, neutral, negative
Positive
6
Neutral
16
Negative
2
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
Kalkine Media
Direct company coverage
Merck Stock In Focus As Combination Therapies Shape Healthcare
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Jun 2026 18:53
- Source
- Kalkine Media
Seeking Alpha
Direct company coverage
Merck: Buy The Dip On This Dividend Growth Pharma Leader (NYSE:MRK)
- Tone
- Positive 82/100
- Event
- Capital return
- Published
- 16 Jun 2026 11:15
- Source
- Seeking Alpha
MarketBeat
Direct company coverage
Mariner LLC Has $289.84 Million Stock Position in Merck & Co., Inc. $MRK
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Jun 2026 08:35
- Source
- MarketBeat
Market source
Direct company coverage
Merck Stock Moves Above 50-Day SMA: Assessing Its Investment Case
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Jun 2026 07:00
- Source
- Market source
The Motley Fool
Direct company coverage
Meet the Biotech Stock That's Trouncing Lilly, Merck, and Pfizer in 2026
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 03 Jun 2026 07:00
- Source
- The Motley Fool
Market source
Direct company coverage
Merck & Co. (MRK) Announces Quarterly Dividend
- Tone
- Neutral 50/100
- Event
- Capital return
- Published
- 02 Jun 2026 07:00
- Source
- Market source
Quiver Quantitative
Direct company coverage
Merck shares slide as investors weigh kidney-cancer trial setback ahead of a near-term FDA decision | MRK Stock News
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Jun 2026 07:00
- Source
- Quiver Quantitative
TradingKey
Direct company coverage
Merck & Co Inc Stock (MRK) Moved Down by 3.19% on Jun 1: A Full Analysis
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Jun 2026 07:00
- Source
- TradingKey
Barchart.com
Direct company coverage
Is Merck & Co. Stock Outperforming the S&P 500?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 29 May 2026 07:00
- Source
- Barchart.com
TIKR.com
Direct company coverage
Merck Stock After a 60% Rally From Its Lows: Is It Still Worth Buying at $120?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 28 May 2026 07:00
- Source
- TIKR.com
Market source
Direct company coverage
Here is What to Know Beyond Why Merck & Co., Inc. (MRK) is a Trending Stock
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 28 May 2026 07:00
- Source
- Market source
Trefis
Direct company coverage
Five-Year Tally: Merck Stock Delivers $47 Bil Gain
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 27 May 2026 07:00
- Source
- Trefis
Merck Group
Direct company coverage
PT Merck Tbk Reports 66% Operating Profit Growth & Rp123.2 Billion Dividend in 2025
- Tone
- Positive 82/100
- Event
- Earnings
- Published
- 25 May 2026 07:00
- Source
- Merck Group
Investor's Business Daily
Direct company coverage
Merck Stock Zooms Closer To A Breakout On 'A New Chapter' In Cancer
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 22 May 2026 07:00
- Source
- Investor's Business Daily
Market source
Direct company coverage
Merck Stock Down 7% in a Month: Should Investors Hold or Exit?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 11 May 2026 07:00
- Source
- Market source
Market source
Direct company coverage
Jim Cramer on Merck & Co.: “The Stock’s Starting to Come Back”
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 May 2026 07:00
- Source
- Market source
Market source
Direct company coverage
Merck (MRK) Stock Falls Amid Market Uptick: What Investors Need to Know
- Tone
- Negative 22/100
- Event
- Market update
- Published
- 24 Apr 2026 07:00
- Source
- Market source
Market source
Direct company coverage
Why Merck (MRK) Shares Are Trading Lower Today
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 21 Apr 2026 07:00
- Source
- Market source
Market source
Direct company coverage
Merck (MRK) Stock Sinks As Market Gains: Here's Why
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 13 Apr 2026 07:00
- Source
- Market source
Market source
Direct company coverage
Assessing Merck (MRK) Valuation After Strong Recent Share Price Momentum
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 08 Apr 2026 07:00
- Source
- Market source
Market source
Direct company coverage
Merck Stock Soars 50% in 6 Months: Buy, Hold, or Take Profits?
- Tone
- Positive 82/100
- Event
- Market update
- Published
- 27 Mar 2026 07:00
- Source
- Market source
Universitas Gadjah Mada
Direct company coverage
Meet UGM Alumna Evie Yulin, First Female Country General Manager at Merck Healthcare Asia Pacific
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Dec 2024 08:00
- Source
- Universitas Gadjah Mada
Merck Group
Direct company coverage
Shop Online Merck Products at SigmaAldrich.com
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Mar 2024 08:00
- Source
- Merck Group
TradingView
Direct company coverage
Technical Analysis of PT Merck Tbk (IDX:MERK)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 Mar 2018 09:02
- Source
- TradingView